跳至主要内容
临床试验/IRCT138711281696N1
IRCT138711281696N1已完成3 期

Comparative study of the effect of Cinnagen's interferon beta and Avonex on relapsing-remitting Multiple Sclerosis

Cinnagen Company0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • RRMS as defined by Mc Donald's criteria, Age: 18-50 years, EDSS 0-5.5, signing informed consent

排除标准

  • Pregnancy or the desire to become pregnant during the trial period, major depression or psychiatric problem, history of suicidal attempt, Allergy to INF-beta, IVIG during the past 6 months, Cytotoxic medications, increased liver enzymes >3 times, leucopenia, missing patient for 4 consecutive weeks, plasmapheresis.

研究者

相似试验

Cinnovex versus Avonex clinica Trial | 临床试验